PetMed Express (NASDAQ:PETS – Free Report) had its target price cut by Morgan Stanley from $6.50 to $3.50 in a research report sent to investors on Wednesday morning, Benzinga reports. They currently have an underweight rating on the stock.
PetMed Express Price Performance
PETS opened at $4.17 on Wednesday. PetMed Express has a fifty-two week low of $3.92 and a fifty-two week high of $15.08. The firm has a market capitalization of $88.20 million, a price-to-earnings ratio of -10.69 and a beta of 0.69. The company’s 50 day moving average price is $4.25 and its two-hundred day moving average price is $5.53.
PetMed Express (NASDAQ:PETS – Get Free Report) last posted its quarterly earnings data on Monday, April 15th. The company reported ($0.10) EPS for the quarter. PetMed Express had a negative net margin of 2.92% and a negative return on equity of 1.25%. The firm had revenue of $65.32 million during the quarter.
Institutional Inflows and Outflows
Institutional investors have recently modified their holdings of the stock. CWM LLC lifted its position in shares of PetMed Express by 167.5% during the 4th quarter. CWM LLC now owns 3,378 shares of the company’s stock valued at $26,000 after acquiring an additional 2,115 shares during the period. Nisa Investment Advisors LLC acquired a new position in shares of PetMed Express during the 4th quarter valued at $36,000. Quest Partners LLC acquired a new position in shares of PetMed Express during the 4th quarter valued at $47,000. Oak Thistle LLC acquired a new position in shares of PetMed Express during the 1st quarter valued at $50,000. Finally, Pinnacle Wealth Planning Services Inc. acquired a new position in shares of PetMed Express during the 1st quarter valued at $61,000. Institutional investors and hedge funds own 73.33% of the company’s stock.
About PetMed Express
PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
Read More
Receive News & Ratings for PetMed Express Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for PetMed Express and related companies with MarketBeat.com’s FREE daily email newsletter.
